IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medexus Pharmaceuticals Inc (MEDXF)

Q1 2023 vs Q2 2023

Comparing institutional holders between quarters

Quarters

Q2 2023Q1 2023Q4 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Bard Financial Services, Inc.
UNCHANGED
Shares10,000 from 10,000
Change0 (0%)
Value$14.1K (+$2.2K)
Filed 2023-07-11
Status
Bard Financial Services, Inc.
UNCHANGED10,00010,00000%$11.8K$14.1K+$2.2K2023-07-11
Showing 1 of 1 institutions